Coloplast A/S
Health Care
Current price
Target price 00%
Ranks rating
76
Position in sub-industry
128 / 236
Position in country
140 / 253
Return on Assets, %
12.2
1.6
Net income margin, %
18.3
2.7
EBITDA margin, %
32.2
10.2
Debt to Equity, %
143
13.9
Intangible assets and goodwill, %
64.7
2.7
Revenue CAGR 3Y, %
9.7
11.3
Total Equity change 1Y, %
163.4
-0.3
Revenue Y, % chg
9.5
0
P/E
40.4
25.8
P/BV
13.4
1.5
P/S
7.6
2.8
EV/S
8.4
2.5
EV/EBITDA
26.4
9
Average Analyst recommendation
Hold
Hold
Average upside forecasts, %
917.2
36.5
Forward P/E
35.3
18.3
Dividend Yield, %
2.2
2
Forward Dividend Yield, %
24.6
0.2
Expected dividend per share
3.1
0
Payout Ratio, %
92.9
32.2
Dividend Ex Date
2023-12-08
Competitors
Ranks
-
Shenzhen New Industries Biomedical Engineering Co Ltd
00%
-
EssilorLuxottica SA
00%
-
Hoya Corp
00%
-
Alcon AG
00%
-
ConvaTec Group PLC
00%
-
Coloplast A/S
00%
-
Align Technology Inc
00%
-
DENTSPLY SIRONA Inc
00%
-
Cooper Companies Inc
00%
-
HLB Inc
00%
Ready-made portfolio of the best Russian stocks
- Created by artificial intelligence
- Verified by analysts
- Available even to beginners
Company information
Country
Denmark
Sector
Health Care
Industry group
Health Care Equipment & Services
Industry
Health Care Equipment & Supplies
Sub-sector
Health Care
Capitalization (millions of $)
27434.6
Ticker
CLPBY.PK
ISIN
US19624Y2000
IPO date
1983-01-01
Availability on Russian exchanges
No
Reporting for
2024-02-09
Date fact. publication of reports
2023-12-31
Company Description
Coloplast A/S is a Denmark-based company active within the healthcare sector. It is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostomy Care offering products for people whose intestinal outlet has been rerouted through the abdominal wall, Continence Care products for people suffering from diseases of and damage to the urinary system, Urology Care products for people suffering from diseases of and damage to the kidneys, the urinary system or the male reproductive system and Wound & Skin Care for the treatment of chronic wounds and skin care products for prevention and treatment. The Company supplies products to hospitals, institutions as well as wholesalers and pharmacies.
A step towards better analytics
- find the best promotions through the Screener
- keep an eye on stock valuation
- download detailed reports
and much more after free registration
RegistrationMore convenient from your phone? Download: